Skip to main content
. 2020 Mar 2;16(8):1762–1771. doi: 10.1080/21645515.2019.1705112

Figure 2.

Figure 2.

Cumulative AEI incidence rate (%) by study week, reported by AERC and EHR data combined for fluarix tetra, with 95% CI a, stratified by subject UK CMO risk status.

a95% CI upper and lower limits provided when AEIs reported, from week 37 onwards.AEI: Adverse event of interest; AERC: Adverse event recording card; CMO: Chief Medical Officer; EHR: electronic health record; UK: United Kingdom; 95% CI: 95% Confidence interval (Clopper-Pearson exact CI modified for cluster data).